Showing results (61-70 of 260) with videos related to
Sort By:
Pageof 26
European Journal of Endocrinology|May 31, 2007
Regressive liver adenomatosis following androgenic progestin therapy withdrawal: a case report with a 10-year follow-up and a molecular analysisMagali Svrcek, Emmanuelle Jeannot, Lionel Arrivé, et al.Bulletin Du Cancer|February 13, 2009
[Management of hepatocellular carcinoma. Where are we now? What's next?]Julien Taieb, Jean-Claude Barbare, Tarek Boussaha, et al.Journal of Hepatology|May 10, 2008
The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodulesSandra Rebouissou, Gabrielle Couchy, Louis Libbrecht, et al.Journal of Hepatology|March 8, 2023
The exposome and liver disease - how environmental factors affect liver healthRobert Barouki, Michel Samson, Etienne B Blanc, et al.Hepatology (Baltimore, Md.)|August 16, 2014
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosisJean Charles Nault, Julien Calderaro, Luca Di Tommaso, et al.The Journal of Biological Chemistry|March 24, 2007
HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activationSandra Rebouissou, Sandrine Imbeaud, Charles Balabaud, et al.European Journal of Cancer (Oxford, England : 1990)|July 23, 2011
CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cellsJustin Monnier, Mathieu Boissan, Annie L'Helgoualc'h, et al.Journal of Hepatology|May 18, 2023
RSK2 inactivation cooperates with AXIN1 inactivation or β-catenin activation to promote hepatocarcinogenesisSamantha Schaeffer, Barkha Gupta, Anna-Line Calatayud, et al.European Journal of Gastroenterology & Hepatology|May 1, 2013
Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspectiveMassimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, et al.Oncoimmunology|June 22, 2012
Trial Watch: Monoclonal antibodies in cancer therapyLorenzo Galluzzi, Erika Vacchelli, Wolf Hervé Fridman, et al.Pageof 26